At a glance
- Originator Yamanouchi
- Class Anti-inflammatories
- Mechanism of Action Phospholipase A2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 23 Jul 1998 No-Development-Reported for Inflammation in Japan (Unknown route)
- 19 Jun 1995 New profile
- 19 Jun 1995 Preclinical development for Inflammation in Japan (Unknown route)